SCRA 580FERNAN, CJ FACTS1.Private respondent Ladisla was employed by petitioner Mercury Drug Corporation asa Stock Analyst. 2.He had been with the company for at least two years when he was apprehended bythe representatives of Mercury Drug while in the act of pilfering company property. 3.Private respondent admitted his guilt to the investigating representatives of petitionercompany and executed a handwritten admission. 4.Petitioner, while simultaneously placing private respondent on preventivesuspension, filed before the Department of Labor an application for the termination ofprivate respondent on the grounds of dishonesty and breach of trust. 5.Private respondent opposed the aforesaid application alleging, among others, thathis suspension and proposed dismissal were unfounded and baseless and that hewas not given the opportunity to be heard nor allowed to explain his side before hewas summarily suspended. 6.Petitioner also filed a criminal case against private respondent for attempted qualifiedtheft but the same was dismissed. Later, the case was re-filed with the Regional TrialCourt and private respondent was convicted for the crime of simple theft. 7.The Labor Arbiter rendered its decision sustaining the validity of private respondentsdismissal and granting petitioners clearance but this was reversed by the NationalLabor Relations Commission. ISSUE Whether or not petitioner company has reasonable ground to terminate the employment ofprivate respondent Ladisla. HELD Dismissal of a dishonest employee is to the best interest not only of the management butalso of labor. As a measure of self-protection against acts inimical to its interest, a companyhas the right to dismiss its erring employees. An employer cannot be compelled to continuein employment an employee guilty of acts inimical to its interest, justifying loss of confidencein him. The law does not impose unjust situations on either labor or management. Wetherefore find justification in the termination of private respondent Ladislas employment bypetitioner Mercury Drug Corporatio